{"gene":"IRAK1","run_date":"2026-06-10T01:55:23","timeline":{"discoveries":[{"year":1996,"finding":"IRAK1 (IRAK) was identified as a serine/threonine protein kinase that rapidly associates with the IL-1 receptor type I complex upon IL-1 stimulation and becomes phosphorylated, linking IL-1R engagement to NF-κB activation.","method":"Protein purification, cDNA cloning, co-immunoprecipitation with IL-1RI complex, phosphorylation assay in HEK293 and HeLa cells","journal":"Science","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct biochemical purification and cloning with functional receptor-association assay; foundational paper replicated across subsequent studies","pmids":["8599092"],"is_preprint":false},{"year":1993,"finding":"The Drosophila IRAK1 ortholog Pelle encodes a serine/threonine protein kinase whose catalytic domain is required for biological activity (nuclear import of Dorsal to establish dorsoventral polarity); site-directed mutagenesis of the kinase domain abolishes function.","method":"Molecular cloning, DNA sequence analysis, microinjection of in vitro-synthesized transcripts with site-directed mutations in Drosophila embryos","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis of active-site with direct functional readout in vivo; foundational paper","pmids":["8440018"],"is_preprint":false},{"year":1994,"finding":"Pelle (Drosophila IRAK1 ortholog) functions downstream of Tube in the Toll signaling pathway; Pelle and Tube interact directly, and Tube activates Pelle, as shown by gain-of-function alleles and direct protein interaction.","method":"Genetic epistasis with gain-of-function alleles, direct protein-protein interaction assay in Drosophila embryos","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genetic epistasis combined with direct interaction demonstration; replicated in subsequent structural and biochemical studies","pmids":["7527496"],"is_preprint":false},{"year":1995,"finding":"Pelle (Drosophila IRAK1 ortholog) is recruited to the plasma membrane via interaction with Tube; membrane targeting of Pelle catalytic domain alone is sufficient to induce ventral fates, and Tube-Pelle interaction is required for signal transduction downstream of Toll.","method":"Immunolocalization, yeast two-hybrid, membrane-targeted fusion protein assay in Drosophila embryos","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interaction assays plus functional rescue with membrane-targeting; replicated across multiple labs","pmids":["7635064"],"is_preprint":false},{"year":1997,"finding":"IRAK1 functions as a proximal mediator of IL-1R-induced NF-κB activation, forming a signaling complex with IL-1R, IRAK-2, and MyD88; dominant-negative forms of IRAK-2 or MyD88 attenuate IL-1R-mediated NF-κB activation, establishing IRAK1 at the apex of this complex.","method":"Co-immunoprecipitation, dominant-negative overexpression, NF-κB reporter assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal complex formation and dominant-negative epistasis; widely replicated","pmids":["9374458"],"is_preprint":false},{"year":1998,"finding":"Pelle (Drosophila IRAK1) directly binds the Toll intracytoplasmic domain; Pelle autophosphorylation prevents binding to both Toll and Tube; Pelle phosphorylates Toll within the Pelle-interaction region, providing a regulatory feedback mechanism.","method":"In vitro binding assay with recombinant proteins, autophosphorylation kinase assay, deletion mapping","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with recombinant proteins and mutagenesis, single lab","pmids":["9806920"],"is_preprint":false},{"year":1999,"finding":"The crystal structure of the Pelle–Tube death domain heterodimer was solved; the two death domains form a six-helix bundle in a linear array, with the Tube death domain having an insertion and C-terminal tail making critical contacts; in vivo mutagenesis confirmed that the major heterodimer interface is essential for activity.","method":"X-ray crystallography, in vivo functional mutagenesis in Drosophila","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with orthogonal in vivo mutagenesis validation","pmids":["10589682"],"is_preprint":false},{"year":1999,"finding":"Pelle and Tube death domains form a heterodimeric complex in vitro with a Kd of ~0.5 µM, as demonstrated by yeast two-hybrid, purified protein interaction, surface plasmon resonance, analytical ultracentrifugation, and isothermal titration calorimetry; mutant Tube proteins unable to support signaling also fail to bind Pelle.","method":"Yeast two-hybrid, protein purification, surface plasmon resonance, analytical ultracentrifugation, isothermal titration calorimetry","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biophysical methods measuring direct interaction with quantitative Kd","pmids":["10512628"],"is_preprint":false},{"year":1999,"finding":"Pelle oligomerization (not membrane association alone) is required for its full activation during Toll signaling; the novel protein Pellino associates with the kinase domain of Pelle.","method":"Deletion analysis, oligomerization assays, co-immunoprecipitation in Drosophila cells","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional deletion analysis and pulldown, single lab","pmids":["10330490"],"is_preprint":false},{"year":1996,"finding":"Mouse IRAK1 ortholog (mPLK) is a protein kinase that can autophosphorylate and phosphorylate IκBα in vitro, linking it biochemically to NF-κB regulation.","method":"Recombinant protein expression in bacteria, in vitro kinase assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro kinase assay, single lab, no mutagenesis","pmids":["8663605"],"is_preprint":false},{"year":2001,"finding":"Pelle (Drosophila IRAK1) physically and functionally interacts with dTRAF2 (homolog of human TRAF6); Pelle phosphorylates dTRAF2 in vitro, and co-expression of Pelle and dTRAF2 synergistically activates Dorsal/NF-κB in Schneider cells.","method":"Co-immunoprecipitation, in vitro kinase assay, co-transfection NF-κB reporter assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct kinase assay (Pelle phosphorylates dTRAF2) plus functional epistasis; two orthogonal methods","pmids":["11447260"],"is_preprint":false},{"year":2001,"finding":"Pelle (Drosophila IRAK1) functions as a feedback regulator that downregulates Tube plasma membrane recruitment; kinase-inactive Pelle or elimination of Tube-Pelle interaction dramatically increases Tube recruitment to the ventral membrane.","method":"Confocal immunofluorescence microscopy, allelic series analysis, autophosphorylation and Tube phosphorylation assays","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization imaging plus biochemical kinase assays, multiple alleles tested","pmids":["11731453"],"is_preprint":false},{"year":2002,"finding":"Pelle (Drosophila IRAK1) undergoes concentration-dependent autophosphorylation that is enhanced by activated Toll signaling; autophosphorylated Pelle is far more active in vitro than unphosphorylated Pelle, establishing autophosphorylation as the activation mechanism.","method":"In vitro kinase assay with recombinant Pelle, transfected Schneider cell phosphorylation assay, gain-of-function Toll mutant analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with quantitative kinase activity measurement; corroborated by in vivo data","pmids":["11934858"],"is_preprint":false},{"year":2002,"finding":"IRAK-4 phosphorylates IRAK1 and is required upstream of IRAK1 for IL-1-induced activation and modification of IRAK1; overexpression of dominant-negative IRAK-4 blocks IL-1-induced activation of IRAK1.","method":"In vitro kinase assay (IRAK-4 phosphorylates IRAK1), dominant-negative overexpression, co-immunoprecipitation in a stimulus-dependent manner","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct phosphorylation assay plus epistasis; replicated by independent labs","pmids":["11960013"],"is_preprint":false},{"year":2002,"finding":"IRAK-M prevents dissociation of IRAK1 and IRAK-4 from MyD88 and blocks formation of IRAK1-TRAF6 complexes, thereby negatively regulating TLR/IL-1R signaling; IRAK-M-deficient cells show increased cytokine production and reduced endotoxin tolerance.","method":"Genetic knockout (IRAK-M-/- mice), co-immunoprecipitation of IRAK1-MyD88 and IRAK1-TRAF6 complexes, cytokine measurement","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined molecular phenotype (disrupted IRAK1 complex dissociation) confirmed by Co-IP; widely replicated","pmids":["12150927"],"is_preprint":false},{"year":2004,"finding":"IRAK-4 kinase activity is required for optimal recruitment and activation of IRAK1 upon IL-1 stimulation; IRAK-4-deficient cells reconstituted with kinase-inactive IRAK-4 show impaired IRAK1 activation, NF-κB and JNK signaling, though some signals remain kinase-independent.","method":"IRAK-4-deficient cell reconstitution with wild-type or kinase-inactive IRAK-4, IRAK1 activation assay, NF-κB and JNK reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic reconstitution with kinase-dead mutant, multiple downstream readouts; replicated in other labs","pmids":["15292196"],"is_preprint":false},{"year":2001,"finding":"IRAK1's death domain (but not its kinase activity) is required for NF-κB activation in response to IL-18; the N-proximal undetermined region of IRAK1 is required for NF-κB but not JNK activation in response to IL-18, indicating IRAK1 is a signaling branchpoint; TAK1/TAB1 acts downstream of IRAK1 in IL-18 signaling.","method":"IRAK1-deficient mutant cell line (I1A), domain-deletion mutant analysis, dominant-negative TAK1 overexpression, TAB1 phosphorylation assay","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined cell line lacking IRAK1 plus domain mutant analysis, two signaling readouts, single lab","pmids":["11745395"],"is_preprint":false},{"year":2008,"finding":"IRAK1 translocates to the nucleus upon IL-1 or LPS stimulation, binds the promoter of the NF-κB-regulated gene IκBα, enhances NF-κB p65 binding to the IκBα promoter, and phosphorylates histone H3 at serine 10 in vitro and in vivo, revealing a nuclear function for IRAK1 in NF-κB transcriptional activation.","method":"Nuclear fractionation, chromatin immunoprecipitation (ChIP), in vitro histone H3 kinase assay, NF-κB transcriptional reporter assay","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus in vitro kinase assay plus fractionation, single lab, two orthogonal methods","pmids":["18276832"],"is_preprint":false},{"year":2010,"finding":"Both IRAK1 and IRAK4 directly phosphorylate the TLR adaptor Mal (MyD88 adaptor-like), and this phosphorylation promotes ubiquitination and proteasomal degradation of Mal; kinase-inactive forms of either IRAK have no effect on Mal degradation, establishing Mal as a substrate.","method":"In vitro kinase assay (IRAK1/IRAK4 phosphorylate Mal), co-expression ubiquitination assay, IRAK1/4 inhibitor treatment, siRNA knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct in vitro kinase assay plus kinase-dead controls plus pharmacological inhibitor; single lab, two orthogonal methods","pmids":["20400509"],"is_preprint":false},{"year":2011,"finding":"Endotoxin tolerance ablates K63-linked polyubiquitination of IRAK1 and TRAF6, compromises assembly of IRAK1-TRAF6 and IRAK1-IKKγ signaling platforms, and this coincides with increased A20 expression and sustained A20-IRAK1 associations; A20 shRNA knockdown abolishes LPS tolerance, establishing A20 as the deubiquitinase that targets IRAK1 ubiquitination.","method":"Co-immunoprecipitation, ubiquitination assay (K63-linked), A20 overexpression/shRNA knockdown, NF-κB reporter assay in THP1 cells and human monocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (IP, ubiquitination assay, shRNA rescue); mechanistically defines A20-IRAK1 axis in tolerance","pmids":["21220427"],"is_preprint":false},{"year":2013,"finding":"IRAK1 kinase activity is required for TLR-triggered rapid (priming-independent) NLRP3 inflammasome activation; IRAK1-deficient macrophages show compromised rapid caspase-1 cleavage, pyroptosis, and NLRP3 complex assembly upon simultaneous TLR and NLRP3 activation by Listeria monocytogenes.","method":"IRAK1-deficient macrophages (genetic KO), caspase-1 cleavage assay, pyroptosis assay, NLRP3 complex immunoprecipitation, pharmacological kinase inhibition","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple downstream readouts (caspase-1, pyroptosis, complex assembly) plus pharmacological validation, single lab","pmids":["24379360"],"is_preprint":false},{"year":2013,"finding":"Pelle (Drosophila IRAK1) acts as an IκB kinase (IKK) functional equivalent in the Toll pathway, directly phosphorylating Cactus (IκBα homolog) to trigger its βTrCP/Slimb-dependent ubiquitination and proteasomal degradation, enabling Dorsal nuclear entry.","method":"Genetic epistasis, Cactus phosphorylation assay, Slimb (βTrCP) requirement assay in cultured Drosophila cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and cell-based epistasis, single lab; direct phosphorylation inference from pathway analysis","pmids":["24086459"],"is_preprint":false},{"year":2017,"finding":"The crystal structure of the human IRAK1 kinase domain in complex with a small-molecule inhibitor was solved; the IRAK1 kinase domain is constitutively monomeric regardless of phosphorylation state (unlike IRAK4 which homodimerizes when unphosphorylated); phosphorylated IRAK4 kinase domain forms heterodimers with IRAK1 kinase domain, revealing a two-step activation mechanism in the Myddosome.","method":"X-ray crystallography, size-exclusion chromatography, phosphorylation-state controlled heterodimer assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus orthogonal biochemical dimerization assays; rigorous single study with multiple methods","pmids":["29208712"],"is_preprint":false},{"year":2017,"finding":"IRAK1 is inactive in unstimulated cells and is activated by IL-1 or TLR stimulation in human cells; this activation is not prevented by pharmacological IRAK4 inhibition and is not reversed by dephosphorylation/deubiquitylation, suggesting IRAK1 is activated by an allosteric mechanism induced by its interaction with IRAK4 rather than by a covalent modification.","method":"Novel cell-extract kinase assays using Pellino1 as substrate, specific pharmacological IRAK1/IRAK4 inhibitors, phosphatase/deubiquitylase treatment in HEK293, THP1 monocytes, primary human macrophages","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — novel quantitative kinase assays with pharmacological controls in multiple human cell types; multiple orthogonal approaches","pmids":["28512203"],"is_preprint":false},{"year":2003,"finding":"Atypical protein kinase C iota (PKCι) phosphorylates IRAK1 at Thr66 within the death domain; mutation of Thr66 to Ala impairs IRAK1 autokinase activity and reduces PKCι-IRAK1 association, impairing NGF- and IL-1-induced NF-κB activation; PKCι lies upstream of IRAK1 in the NF-κB pathway.","method":"In vitro kinase assay (PKCι phosphorylates IRAK1 peptide), site-directed mutagenesis (T66A), co-immunoprecipitation, NF-κB reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase assay plus mutagenesis plus Co-IP, single lab","pmids":["14684752"],"is_preprint":false},{"year":2017,"finding":"K48-linked ubiquitination of IRAK1 at Lys134 by β-TrCP is required for TLR9-induced IRAK1 membrane-to-cytoplasm trafficking and downstream NF-κB/MAPK activation; glucocorticoid receptor physically interacts with IRAK1 and interferes with β-TrCP-IRAK1 interaction to suppress TLR9-specific (not TLR4) inflammation.","method":"Co-immunoprecipitation (GR-IRAK1 interaction), ubiquitination assay (K48-linked at Lys134), IRAK1 K134 mutation, macrophage glucocorticoid receptor knockout, NF-κB/MAPK activation assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct interaction demonstrated, site-specific ubiquitination mapped by mutagenesis, genetic KO validation, multiple readouts; single lab","pmids":["29038250"],"is_preprint":false},{"year":2019,"finding":"Viperin interacts with both IRAK1 and TRAF6; IRAK1 and TRAF6 together stimulate viperin enzymatic activity ~10-fold; TRAF6-mediated K63-linked ubiquitination of IRAK1 requires the association of viperin with both IRAK1 and TRAF6, coupling innate immune signaling to antiviral ddhCTP synthesis.","method":"Co-immunoprecipitation (viperin-IRAK1-TRAF6 in HEK293T), viperin activity reconstitution assay, ubiquitination assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus reconstituted enzymatic assay; single lab, two orthogonal methods","pmids":["30872404"],"is_preprint":false},{"year":2019,"finding":"IRAK1 drives radiotherapy resistance via a pathway involving IRAK4 and TRAF6, but not MyD88; radiation-activated IRAK1 prevents PIDDosome-mediated caspase-2 apoptosis; IRAK1 requires PIN1 (a prolyl isomerase) for its activation in response to ionizing radiation.","method":"Genetic IRAK1 inhibition/KO in tumor models, epistasis with MyD88/TRAF6/IRAK4 knockdown, caspase-2 and PIDDosome assays, pharmacological IRAK1-PIN1 co-inhibition in xenograft models","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in multiple models with defined molecular readouts (PIDDosome, caspase-2), pharmacological validation; single lab, orthogonal methods","pmids":["30664786"],"is_preprint":false},{"year":2015,"finding":"IRAK1/4 signaling activates the E3 ubiquitin ligase TRAF6, increasing K63-linked ubiquitination and enhancing stability of the antiapoptotic protein MCL1; IRAK inhibition reduces MCL1 stability, sensitizing T-ALL cells to apoptosis-inducing combination therapy.","method":"shRNA knockdown of IRAK1/IRAK4, pharmacological IRAK1/4 inhibition, K63-ubiquitination assay of TRAF6, MCL1 stability assay, leukemia xenograft model","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological KD with ubiquitination and protein stability assays; single lab, multiple readouts","pmids":["25642772"],"is_preprint":false},{"year":2023,"finding":"In MDS/AML, IRAK1 and IRAK4 operate via noncanonical MyD88-independent pathways; inhibiting IRAK4 elicits functional compensation by IRAK1; combined IRAK1+IRAK4 cotargeting suppresses leukemic stem/progenitor cell function and induces differentiation; IRAK1/IRAK4 preserve the undifferentiated state through pathways converging on PRC2 and JAK-STAT signaling.","method":"Genetic knockdown/knockout, dual IRAK1/4 inhibitor (KME-2780), proteomics, MyD88 genetic epistasis, xenograft and patient-derived cell models","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological approaches with genomic/proteomic analyses in patient-derived models; single lab, multiple orthogonal methods","pmids":["37172199"],"is_preprint":false},{"year":2021,"finding":"In FGFR1-driven hematological malignancies (SCLL), IRAK1 promotes immune evasion by regulating IFN-γ production from leukemia cells, which induces MDSC expansion to suppress T cell-mediated tumor killing; IRAK1 KO eliminates disease in immunocompetent but not immunodeficient mice.","method":"CRISPR/Cas9 IRAK1 knockout, syngeneic xenograft, T-cell depletion, IFNG KO cells, IFNGR1-null host mice, cytokine profiling","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with rigorous immune depletion and genetic epistasis; single lab, multiple orthogonal approaches","pmids":["34906138"],"is_preprint":false},{"year":2021,"finding":"IRAK1 binds to PRDX1 and prevents its ubiquitination and degradation by E3 ubiquitin ligase HECTD3 (whose DOC and HECT domains both interact with PRDX1), thereby promoting radioresistance in glioma by suppressing autophagic cell death.","method":"Co-IP, LC-MS/MS, GST pull-down, ubiquitination assay, IRAK1 knockdown with in vitro and in vivo radiosensitivity assays, ChIP and dual-luciferase for FOXA2-IRAK1 transcription axis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple interaction methods (Co-IP, GST pulldown, MS) plus functional rescue; single lab","pmids":["37031183"],"is_preprint":false},{"year":2021,"finding":"IRAK1 scaffolding function (rather than kinase activity) is required for survival of ABC DLBCL cells harboring MyD88 mutation; IRAK1-targeted degraders (PROTACs) potently degrade IRAK1 and inhibit downstream NF-κB signaling and cell proliferation.","method":"IRAK1 PROTAC degraders, cell viability assays, NF-κB pathway reporter assay in MyD88-mutant ABC DLBCL cells","journal":"Journal of medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological protein degradation with downstream pathway readout; scaffolding vs. kinase distinction established by comparing degrader vs. kinase inhibitor effects","pmids":["34279092"],"is_preprint":false},{"year":2015,"finding":"Pelle (Drosophila IRAK1) physically interacts with dFoxO and directly phosphorylates dFoxO, promoting its cytoplasmic-to-nuclear translocation and upregulation of Thor/4E-BP transcription, revealing a Toll-independent role for Pelle in regulating apoptotic cell death.","method":"Co-immunoprecipitation (Pelle-dFoxO), in vitro kinase assay (Pelle phosphorylates dFoxO), nuclear translocation assay, genetic loss-of-function in Drosophila wing tissue","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — direct kinase assay plus Co-IP plus in vivo genetic phenotype; single lab","pmids":["26474173"],"is_preprint":false}],"current_model":"IRAK1 is a serine/threonine kinase that, upon IL-1R or TLR stimulation, is recruited to the receptor complex via death-domain interactions with MyD88/IRAK4, where it is activated allosterically through heterodimerization with phosphorylated IRAK4; once active, IRAK1 undergoes K63-linked polyubiquitination by TRAF6, dissociates from the receptor complex to activate downstream NF-κB, MAPK, and inflammasome (NLRP3) pathways, and also translocates to the nucleus to directly phosphorylate histone H3 and enhance NF-κB transcriptional output; its activity is negatively regulated by IRAK-M (which blocks IRAK1-TRAF6 complex formation), A20 (which deubiquitinates IRAK1), and autophosphorylation-dependent dissociation from the receptor, while additional non-canonical functions include regulation of apoptosis via dFoxO phosphorylation, MCL1 stabilization via TRAF6/K63-ubiquitination, and radioresistance via PRDX1 stabilization and PIN1-dependent activation."},"narrative":{"mechanistic_narrative":"IRAK1 is a serine/threonine protein kinase that serves as a proximal signal transducer of the IL-1 receptor and Toll-like receptor family, coupling receptor engagement to NF-κB activation [PMID:8599092, PMID:9374458]. Its core signaling logic is conserved from the Drosophila ortholog Pelle, which acts downstream of Tube in the Toll dorsoventral patterning pathway: Pelle is recruited to the membrane through a death-domain heterodimer with Tube and, once oligomerized, drives nuclear import of the NF-κB-like factor Dorsal [PMID:7527496, PMID:7635064, PMID:10589682, PMID:10330490]. In the mammalian pathway IRAK1 assembles with MyD88 and IRAK-2 at the receptor [PMID:9374458] and is recruited and activated by upstream IRAK4, whose kinase activity phosphorylates IRAK1 and is required for optimal IRAK1 activation [PMID:11960013, PMID:15292196]; structurally, the IRAK1 kinase domain remains monomeric and is licensed by forming a heterodimer with phosphorylated IRAK4, defining a two-step Myddosome activation mechanism that operates allosterically rather than through a single covalent mark [PMID:29208712, PMID:28512203]. Activated IRAK1 feeds into NF-κB, MAPK/JNK, and the TAK1/TAB1 module, and acts as a signaling branchpoint in which the death domain and N-proximal region, not kinase activity, are needed for some outputs [PMID:11745395]; IRAK1 also enables priming-independent NLRP3 inflammasome assembly and rapid caspase-1 activation in a kinase-dependent manner [PMID:24379360]. Beyond cytoplasmic signaling, IRAK1 translocates to the nucleus, binds NF-κB target promoters, and phosphorylates histone H3 at serine 10 to enhance transcriptional output [PMID:18276832]. IRAK1 directly phosphorylates substrates including the adaptor Mal, targeting it for ubiquitin-dependent degradation [PMID:20400509]. Its activity is tuned by multiple negative regulators—IRAK-M blocks IRAK1 dissociation from MyD88 and formation of IRAK1-TRAF6 complexes [PMID:12150927], the deubiquitinase A20 reverses K63-linked IRAK1 ubiquitination during endotoxin tolerance [PMID:21220427], and the glucocorticoid receptor interferes with β-TrCP-mediated K48 ubiquitination required for IRAK1 trafficking [PMID:29038250]. IRAK1 additionally functions in malignancy and stress responses, promoting radioresistance through PIN1-dependent activation and PRDX1 stabilization, stabilizing the anti-apoptotic protein MCL1 via TRAF6/K63-ubiquitination, and sustaining leukemic stem/progenitor states, in part through scaffolding rather than catalytic functions [PMID:30664786, PMID:25642772, PMID:37031183, PMID:34279092, PMID:37172199].","teleology":[{"year":1993,"claim":"Established that the IRAK1 ortholog is a catalytically essential kinase whose function is to relay a receptor signal to nuclear transcription factor activation, defining the gene as an essential transducer rather than a structural component.","evidence":"Cloning and active-site mutagenesis of Drosophila Pelle with in vivo Dorsal nuclear-import readout","pmids":["8440018"],"confidence":"High","gaps":["Mammalian substrates not yet identified","Mechanism of kinase activation undefined"]},{"year":1995,"claim":"Showed that the kinase is positioned at the membrane through an upstream death-domain adaptor, answering how the cytoplasmic kinase is recruited to an activated receptor.","evidence":"Yeast two-hybrid, immunolocalization, and membrane-targeted fusion rescue of Pelle-Tube interaction in Drosophila embryos","pmids":["7635064"],"confidence":"High","gaps":["Stoichiometry and dynamics of recruitment not resolved","Connection to receptor occupancy quantitative only later"]},{"year":1996,"claim":"Identified mammalian IRAK1 biochemically and placed it physically at the IL-1 receptor, connecting IL-1R engagement to NF-κB activation in human cells.","evidence":"Protein purification, cDNA cloning, and Co-IP with IL-1RI plus phosphorylation assay in HEK293/HeLa; parallel mouse mPLK in vitro kinase assay on IκBα","pmids":["8599092","8663605"],"confidence":"High","gaps":["Direct physiological substrates unproven (IκBα phosphorylation only in vitro)","Upstream activating kinase unknown"]},{"year":1997,"claim":"Defined the proximal receptor complex composition, establishing IRAK1 at the apex of an IL-1R/MyD88/IRAK-2 signaling assembly.","evidence":"Co-IP and dominant-negative epistasis with NF-κB reporter assays","pmids":["9374458"],"confidence":"High","gaps":["Order of assembly and activation step undefined","How IRAK1 leaves the complex unknown"]},{"year":1998,"claim":"Revealed an autoregulatory feedback loop in which kinase autophosphorylation governs receptor and adaptor binding, explaining signal termination.","evidence":"In vitro binding and autophosphorylation kinase assays with recombinant Pelle and Toll/Tube","pmids":["9806920"],"confidence":"High","gaps":["Conservation of Toll-direct phosphorylation in mammals not shown","Single-lab in vitro reconstitution"]},{"year":1999,"claim":"Determined the structural basis of kinase recruitment by solving the death-domain heterodimer and measuring its affinity, validating the interface as functionally essential.","evidence":"X-ray crystallography of Pelle-Tube death-domain bundle, SPR/AUC/ITC affinity measurement, and in vivo mutagenesis","pmids":["10589682","10512628","10330490"],"confidence":"High","gaps":["Mammalian Myddosome geometry not yet addressed","Role of oligomerization beyond membrane association partially defined"]},{"year":2002,"claim":"Established the upstream kinase relationship and the activation mechanism, showing IRAK4 phosphorylates and is required to activate IRAK1, and that autophosphorylation potentiates kinase activity.","evidence":"In vitro IRAK4-on-IRAK1 phosphorylation assay with dominant-negative epistasis; concentration-dependent Pelle autophosphorylation kinase assays","pmids":["11960013","11934858","11731453"],"confidence":"High","gaps":["Whether activation is covalent or allosteric not yet distinguished","Distinct kinase-dependent vs kinase-independent outputs unresolved"]},{"year":2002,"claim":"Defined the principal physiological brake on IRAK1 signaling, showing IRAK-M prevents IRAK1 dissociation from MyD88 and blocks IRAK1-TRAF6 complex formation.","evidence":"IRAK-M knockout mice with Co-IP of IRAK1 complexes and cytokine/tolerance phenotyping","pmids":["12150927"],"confidence":"High","gaps":["Molecular mechanism of complex stabilization not structurally defined","Other negative regulators not yet known"]},{"year":2008,"claim":"Uncovered a nuclear role for IRAK1, showing it directly modifies chromatin at NF-κB target genes to enhance transcription.","evidence":"Nuclear fractionation, ChIP at the IκBα promoter, and in vitro/in vivo histone H3 S10 kinase assay","pmids":["18276832"],"confidence":"Medium","gaps":["Nuclear translocation mechanism unknown","Genome-wide chromatin targets not mapped","Single lab"]},{"year":2010,"claim":"Identified a direct IRAK1 substrate, showing IRAK1 phosphorylates the TLR adaptor Mal to drive its degradation, providing a kinase-dependent feedback on signaling.","evidence":"In vitro kinase assay with kinase-dead controls, ubiquitination assay, inhibitor and siRNA validation","pmids":["20400509"],"confidence":"High","gaps":["In vivo significance of Mal turnover not quantified","Single lab"]},{"year":2011,"claim":"Defined the deubiquitinase that resets IRAK1, showing A20 removes K63-linked ubiquitin from IRAK1 during endotoxin tolerance and disrupts downstream platform assembly.","evidence":"Co-IP, K63 ubiquitination assays, and A20 shRNA rescue in THP1 cells and human monocytes","pmids":["21220427"],"confidence":"High","gaps":["Direct A20 catalysis on IRAK1 inferred from association","Site of K63 linkage on IRAK1 not mapped here"]},{"year":2013,"claim":"Expanded IRAK1 output to inflammasome control, showing kinase activity is required for rapid priming-independent NLRP3 activation.","evidence":"IRAK1-deficient macrophages with caspase-1 cleavage, pyroptosis, NLRP3 complex IP, and inhibitor validation","pmids":["24379360"],"confidence":"High","gaps":["Direct IRAK1 substrate within the NLRP3 module unknown","Single lab"]},{"year":2017,"claim":"Resolved the long-standing question of how IRAK1 is activated, showing the IRAK1 kinase domain is monomeric and is licensed allosterically by heterodimerization with phosphorylated IRAK4 rather than by a single covalent mark.","evidence":"Crystal structure of human IRAK1 kinase domain, SEC dimerization assays, and phosphatase/deubiquitylase-resistant activation in multiple human cell types using Pellino1 substrate assays","pmids":["29208712","28512203"],"confidence":"High","gaps":["Precise allosteric conformational change not visualized","Relationship between allosteric activation and downstream ubiquitination not fully integrated"]},{"year":2003,"claim":"Identified an additional upstream regulatory input, with atypical PKCι phosphorylating IRAK1 at Thr66 to support autokinase activity and NF-κB signaling.","evidence":"In vitro kinase assay, T66A mutagenesis, Co-IP, and NF-κB reporter","pmids":["14684752"],"confidence":"Medium","gaps":["Physiological contexts requiring PKCι input not delineated","Single lab"]},{"year":2017,"claim":"Defined a ubiquitin-dependent trafficking step and its regulation, showing β-TrCP-mediated K48 ubiquitination at Lys134 drives TLR9-induced IRAK1 membrane-to-cytoplasm trafficking and that the glucocorticoid receptor suppresses this.","evidence":"Co-IP, site-specific ubiquitination mapping with K134 mutation, macrophage GR knockout, and NF-κB/MAPK readouts","pmids":["29038250"],"confidence":"High","gaps":["TLR-specificity mechanism (TLR9 vs TLR4) not fully explained","Single lab"]},{"year":2019,"claim":"Linked IRAK1 signaling to antiviral metabolism, showing viperin bridges IRAK1 and TRAF6 to enable IRAK1 K63-ubiquitination and stimulate viperin enzymatic activity.","evidence":"Reciprocal Co-IP and viperin activity reconstitution with ubiquitination assays in HEK293T","pmids":["30872404"],"confidence":"Medium","gaps":["In vivo relevance to antiviral defense not established","Single lab"]},{"year":2019,"claim":"Established a non-canonical, MyD88-independent IRAK1 function in radioresistance requiring PIN1 and blocking PIDDosome-mediated apoptosis.","evidence":"Genetic IRAK1 inhibition/KO in tumor models, epistasis with MyD88/TRAF6/IRAK4, caspase-2/PIDDosome assays, and pharmacological IRAK1-PIN1 co-inhibition in xenografts","pmids":["30664786"],"confidence":"High","gaps":["Mechanism of PIN1-dependent IRAK1 activation undefined","Single lab"]},{"year":2015,"claim":"Connected IRAK1 to apoptosis control through both a kinase-substrate route in flies and an anti-apoptotic stabilization route in cancer cells.","evidence":"Pelle-dFoxO Co-IP, in vitro kinase assay and Drosophila genetics; IRAK1/4 knockdown with TRAF6 K63-ubiquitination and MCL1 stability assays in T-ALL","pmids":["26474173","25642772"],"confidence":"Medium","gaps":["Conservation of dFoxO phosphorylation in mammals not shown","Whether MCL1 stabilization requires IRAK1 kinase activity not resolved"]},{"year":2021,"claim":"Defined oncogenic IRAK1 roles spanning immune evasion, radioresistance via PRDX1 stabilization, and scaffolding-dependent survival, separating catalytic from non-catalytic functions.","evidence":"CRISPR IRAK1 KO with immune-depletion epistasis; Co-IP/GST pulldown/MS for PRDX1-HECTD3 axis; IRAK1 PROTAC degraders vs kinase inhibitors in MyD88-mutant DLBCL","pmids":["34906138","37031183","34279092"],"confidence":"Medium","gaps":["Generality of scaffolding-vs-kinase dependence across tumor types unclear","Each finding from a single lab"]},{"year":2023,"claim":"Established functional redundancy with IRAK4 in leukemia, showing IRAK4 inhibition triggers IRAK1 compensation and that dual targeting collapses leukemic stem-cell programs.","evidence":"Genetic knockdown/KO, dual IRAK1/4 inhibitor, proteomics, MyD88 epistasis, and patient-derived xenograft models","pmids":["37172199"],"confidence":"Medium","gaps":["Direct molecular link from IRAK1 to PRC2/JAK-STAT not defined","Single lab"]},{"year":null,"claim":"How IRAK1's allosteric kinase activation, K63/K48 ubiquitination states, nuclear chromatin function, and scaffolding-only roles are integrated into a single regulated cycle, and which functions depend on catalysis versus scaffolding in each disease context, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model of the activated Myddosome with IRAK1 in human cells","Comprehensive in vivo substrate map lacking","Kinase-dependent vs scaffolding contributions not systematically separated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,13,18,17,24]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,9,18,33]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[22,12]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[4,0]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[32,26]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,25]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[25,19]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[17]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,4,14,20]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4,13,22]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[17]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[27,28,33]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[28,29,30,31,32]}],"complexes":["Myddosome (MyD88-IRAK4-IRAK1)","IRAK1-TRAF6 complex","NLRP3 inflammasome"],"partners":["IRAK4","MYD88","TRAF6","IRAK2","TUBE","PRDX1","PIN1","PRKCI"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P51617","full_name":"Interleukin-1 receptor-associated kinase 1","aliases":[],"length_aa":712,"mass_kda":76.5,"function":"Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3","subcellular_location":"Cytoplasm; Nucleus; Lipid droplet","url":"https://www.uniprot.org/uniprotkb/P51617/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/IRAK1","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000184216","cell_line_id":"CID001188","localizations":[{"compartment":"cytoplasmic","grade":3}],"interactors":[{"gene":"FKBP5","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001188","total_profiled":1310},"omim":[{"mim_id":"617649","title":"UBIQUITIN-CONJUGATING ENZYME E2 O; UBE2O","url":"https://www.omim.org/entry/617649"},{"mim_id":"615375","title":"INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 1-BINDING PROTEIN 1; IRAK1BP1","url":"https://www.omim.org/entry/615375"},{"mim_id":"614798","title":"PELLINO E3 UBIQUITIN PROTEIN LIGASE 2; PELI2","url":"https://www.omim.org/entry/614798"},{"mim_id":"614797","title":"PELLINO E3 UBIQUITIN PROTEIN LIGASE 1; PELI1","url":"https://www.omim.org/entry/614797"},{"mim_id":"610567","title":"MICRO RNA 146B; MIR146B","url":"https://www.omim.org/entry/610567"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/IRAK1"},"hgnc":{"alias_symbol":["IRAK","pelle"],"prev_symbol":[]},"alphafold":{"accession":"P51617","domains":[{"cath_id":"1.10.533.10","chopping":"25-102","consensus_level":"high","plddt":90.4172,"start":25,"end":102},{"cath_id":"3.30.200.20","chopping":"196-291","consensus_level":"medium","plddt":88.6839,"start":196,"end":291},{"cath_id":"1.10.510.10","chopping":"293-449_464-526","consensus_level":"medium","plddt":88.6615,"start":293,"end":526}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51617","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51617-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51617-F1-predicted_aligned_error_v6.png","plddt_mean":68.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=IRAK1","jax_strain_url":"https://www.jax.org/strain/search?query=IRAK1"},"sequence":{"accession":"P51617","fasta_url":"https://rest.uniprot.org/uniprotkb/P51617.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51617/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51617"}},"corpus_meta":[{"pmid":"12150927","id":"PMC_12150927","title":"IRAK-M is a negative regulator of Toll-like receptor signaling.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12150927","citation_count":1120,"is_preprint":false},{"pmid":"9374458","id":"PMC_9374458","title":"IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.","date":"1997","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9374458","citation_count":944,"is_preprint":false},{"pmid":"8599092","id":"PMC_8599092","title":"IRAK: a kinase associated with the interleukin-1 receptor.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8599092","citation_count":743,"is_preprint":false},{"pmid":"11923871","id":"PMC_11923871","title":"Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.","date":"2002","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/11923871","citation_count":628,"is_preprint":false},{"pmid":"11960013","id":"PMC_11960013","title":"IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11960013","citation_count":522,"is_preprint":false},{"pmid":"12620219","id":"PMC_12620219","title":"Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12620219","citation_count":451,"is_preprint":false},{"pmid":"10383454","id":"PMC_10383454","title":"IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10383454","citation_count":343,"is_preprint":false},{"pmid":"21057262","id":"PMC_21057262","title":"Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.","date":"2010","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21057262","citation_count":319,"is_preprint":false},{"pmid":"19321712","id":"PMC_19321712","title":"Evolutionary history and stress regulation of plant receptor-like kinase/pelle genes.","date":"2009","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19321712","citation_count":298,"is_preprint":false},{"pmid":"21734245","id":"PMC_21734245","title":"Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.","date":"2011","source":"Clinical microbiology reviews","url":"https://pubmed.ncbi.nlm.nih.gov/21734245","citation_count":294,"is_preprint":false},{"pmid":"24379360","id":"PMC_24379360","title":"IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24379360","citation_count":234,"is_preprint":false},{"pmid":"17890055","id":"PMC_17890055","title":"IRAK1: a critical signaling mediator of innate immunity.","date":"2007","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/17890055","citation_count":225,"is_preprint":false},{"pmid":"8440018","id":"PMC_8440018","title":"pelle encodes a protein kinase required to establish dorsoventral polarity in the Drosophila embryo.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8440018","citation_count":191,"is_preprint":false},{"pmid":"21443627","id":"PMC_21443627","title":"The RLK/Pelle family of kinases.","date":"2011","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21443627","citation_count":178,"is_preprint":false},{"pmid":"12297423","id":"PMC_12297423","title":"IRAK-4 as the central TIR signaling mediator in innate immunity.","date":"2002","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12297423","citation_count":169,"is_preprint":false},{"pmid":"10589682","id":"PMC_10589682","title":"Three-dimensional structure of a complex between the death domains of Pelle and Tube.","date":"1999","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/10589682","citation_count":145,"is_preprint":false},{"pmid":"23255009","id":"PMC_23255009","title":"Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans.","date":"2012","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23255009","citation_count":139,"is_preprint":false},{"pmid":"36775818","id":"PMC_36775818","title":"MiR146a-loaded engineered exosomes released from silk fibroin patch promote diabetic wound healing by targeting IRAK1.","date":"2023","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36775818","citation_count":137,"is_preprint":false},{"pmid":"25290089","id":"PMC_25290089","title":"IRAK signalling in cancer.","date":"2014","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25290089","citation_count":134,"is_preprint":false},{"pmid":"19689377","id":"PMC_19689377","title":"IRAK-4 inhibitors for inflammation.","date":"2009","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19689377","citation_count":120,"is_preprint":false},{"pmid":"7527496","id":"PMC_7527496","title":"Activation of the kinase Pelle by Tube in the dorsoventral signal transduction pathway of Drosophila embryo.","date":"1994","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7527496","citation_count":115,"is_preprint":false},{"pmid":"30279971","id":"PMC_30279971","title":"Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30279971","citation_count":113,"is_preprint":false},{"pmid":"15292196","id":"PMC_15292196","title":"The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15292196","citation_count":113,"is_preprint":false},{"pmid":"23376919","id":"PMC_23376919","title":"IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production.","date":"2013","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/23376919","citation_count":113,"is_preprint":false},{"pmid":"10330490","id":"PMC_10330490","title":"Oligomerisation of Tube and Pelle leads to nuclear localisation of dorsal.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10330490","citation_count":111,"is_preprint":false},{"pmid":"28216638","id":"PMC_28216638","title":"Thymoquinone: An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28216638","citation_count":104,"is_preprint":false},{"pmid":"29483095","id":"PMC_29483095","title":"IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29483095","citation_count":92,"is_preprint":false},{"pmid":"25955717","id":"PMC_25955717","title":"Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway.","date":"2015","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/25955717","citation_count":91,"is_preprint":false},{"pmid":"36865541","id":"PMC_36865541","title":"Regulation of innate immune signaling by IRAK proteins.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36865541","citation_count":84,"is_preprint":false},{"pmid":"31917263","id":"PMC_31917263","title":"IRAK family in inflammatory autoimmune diseases.","date":"2020","source":"Autoimmunity reviews","url":"https://pubmed.ncbi.nlm.nih.gov/31917263","citation_count":82,"is_preprint":false},{"pmid":"34743084","id":"PMC_34743084","title":"IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies.","date":"2022","source":"Current opinion in hematology","url":"https://pubmed.ncbi.nlm.nih.gov/34743084","citation_count":77,"is_preprint":false},{"pmid":"21220427","id":"PMC_21220427","title":"Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21220427","citation_count":77,"is_preprint":false},{"pmid":"28512203","id":"PMC_28512203","title":"The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists.","date":"2017","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/28512203","citation_count":73,"is_preprint":false},{"pmid":"7635064","id":"PMC_7635064","title":"Interaction of the pelle kinase with the membrane-associated protein tube is required for transduction of the dorsoventral signal in Drosophila embryos.","date":"1995","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7635064","citation_count":68,"is_preprint":false},{"pmid":"8244004","id":"PMC_8244004","title":"Genetic characterization of tube and pelle, genes required for signaling between Toll and dorsal in the specification of the dorsal-ventral pattern of the Drosophila embryo.","date":"1993","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8244004","citation_count":67,"is_preprint":false},{"pmid":"29208712","id":"PMC_29208712","title":"Crystal structure of human IRAK1.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29208712","citation_count":65,"is_preprint":false},{"pmid":"21390243","id":"PMC_21390243","title":"IRAK-M regulation and function in host defense and immune homeostasis.","date":"2010","source":"Infectious disease reports","url":"https://pubmed.ncbi.nlm.nih.gov/21390243","citation_count":65,"is_preprint":false},{"pmid":"25642772","id":"PMC_25642772","title":"Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.","date":"2015","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/25642772","citation_count":65,"is_preprint":false},{"pmid":"24379523","id":"PMC_24379523","title":"IRAK1/4-targeted anti-inflammatory action of caffeic acid.","date":"2013","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/24379523","citation_count":64,"is_preprint":false},{"pmid":"11447260","id":"PMC_11447260","title":"Physical and functional interactions between Drosophila TRAF2 and Pelle kinase contribute to Dorsal activation.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11447260","citation_count":63,"is_preprint":false},{"pmid":"17046325","id":"PMC_17046325","title":"IRAK-4--a shared NF-kappaB activator in innate and acquired immunity.","date":"2006","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17046325","citation_count":60,"is_preprint":false},{"pmid":"17880891","id":"PMC_17880891","title":"NF-kappaB, IkappaB, and IRAK control glutamate receptor density at the Drosophila NMJ.","date":"2007","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/17880891","citation_count":60,"is_preprint":false},{"pmid":"25320238","id":"PMC_25320238","title":"IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigens.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25320238","citation_count":57,"is_preprint":false},{"pmid":"34248968","id":"PMC_34248968","title":"SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34248968","citation_count":56,"is_preprint":false},{"pmid":"18276832","id":"PMC_18276832","title":"Interleukin-1 receptor-associated kinase (IRAK) -1-mediated NF-kappaB activation requires cytosolic and nuclear activity.","date":"2008","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/18276832","citation_count":55,"is_preprint":false},{"pmid":"20400509","id":"PMC_20400509","title":"IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal).","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20400509","citation_count":52,"is_preprint":false},{"pmid":"37433841","id":"PMC_37433841","title":"MicroRNA-146a negatively regulates inflammation via the IRAK1/TRAF6/NF-κB signaling pathway in dry eye.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37433841","citation_count":52,"is_preprint":false},{"pmid":"11731453","id":"PMC_11731453","title":"The protein kinase Pelle mediates feedback regulation in the Drosophila Toll signaling pathway.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11731453","citation_count":49,"is_preprint":false},{"pmid":"30872404","id":"PMC_30872404","title":"Viperin interacts with the kinase IRAK1 and the E3 ubiquitin ligase TRAF6, coupling innate immune signaling to antiviral ribonucleotide synthesis.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30872404","citation_count":49,"is_preprint":false},{"pmid":"29693168","id":"PMC_29693168","title":"miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6.","date":"2018","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/29693168","citation_count":48,"is_preprint":false},{"pmid":"10766844","id":"PMC_10766844","title":"The Drosophila tumor necrosis factor receptor-associated factor-1 (DTRAF1) interacts with Pelle and regulates NFkappaB activity.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10766844","citation_count":47,"is_preprint":false},{"pmid":"30664786","id":"PMC_30664786","title":"An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30664786","citation_count":47,"is_preprint":false},{"pmid":"23166766","id":"PMC_23166766","title":"Molecular evolution and structural features of IRAK family members.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23166766","citation_count":47,"is_preprint":false},{"pmid":"9806920","id":"PMC_9806920","title":"Phosphorylation modulates direct interactions between the Toll receptor, Pelle kinase and Tube.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9806920","citation_count":46,"is_preprint":false},{"pmid":"37172199","id":"PMC_37172199","title":"Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML.","date":"2023","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/37172199","citation_count":45,"is_preprint":false},{"pmid":"32255710","id":"PMC_32255710","title":"Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis.","date":"2020","source":"Expert opinion on investigational drugs","url":"https://pubmed.ncbi.nlm.nih.gov/32255710","citation_count":44,"is_preprint":false},{"pmid":"9609827","id":"PMC_9609827","title":"Recruitment of Tube and Pelle to signaling sites at the surface of the Drosophila embryo.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9609827","citation_count":44,"is_preprint":false},{"pmid":"37758100","id":"PMC_37758100","title":"Selenium alleviates lead-induced CIK cells pyroptosis and inflammation through IRAK1/TAK1/IKK pathway.","date":"2023","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37758100","citation_count":42,"is_preprint":false},{"pmid":"8846922","id":"PMC_8846922","title":"Functional interactions between the pelle kinase, Toll receptor, and tube suggest a mechanism for activation of dorsal.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8846922","citation_count":39,"is_preprint":false},{"pmid":"31883536","id":"PMC_31883536","title":"BAP31 regulates IRAK1-dependent neuroinflammation in microglia.","date":"2019","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/31883536","citation_count":38,"is_preprint":false},{"pmid":"20375545","id":"PMC_20375545","title":"Toll-like receptor responses in IRAK-4-deficient neutrophils.","date":"2009","source":"Journal of innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20375545","citation_count":38,"is_preprint":false},{"pmid":"28011933","id":"PMC_28011933","title":"Epigenetic and Transcriptional Regulation of IRAK-M Expression in Macrophages.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28011933","citation_count":37,"is_preprint":false},{"pmid":"18286567","id":"PMC_18286567","title":"IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses.","date":"2008","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18286567","citation_count":36,"is_preprint":false},{"pmid":"15258191","id":"PMC_15258191","title":"Prolonged Toll-like receptor stimulation leads to down-regulation of IRAK-4 protein.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/15258191","citation_count":36,"is_preprint":false},{"pmid":"26512959","id":"PMC_26512959","title":"IRAK1 mediates TLR4-induced ABCA1 downregulation and lipid accumulation in VSMCs.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/26512959","citation_count":34,"is_preprint":false},{"pmid":"18266302","id":"PMC_18266302","title":"IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes.","date":"2008","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18266302","citation_count":33,"is_preprint":false},{"pmid":"37031183","id":"PMC_37031183","title":"Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37031183","citation_count":32,"is_preprint":false},{"pmid":"8663605","id":"PMC_8663605","title":"Developmental and tissue-specific expression of mouse pelle-like protein kinase.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8663605","citation_count":32,"is_preprint":false},{"pmid":"24086459","id":"PMC_24086459","title":"The IRAK homolog Pelle is the functional counterpart of IκB kinase in the Drosophila Toll pathway.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24086459","citation_count":32,"is_preprint":false},{"pmid":"33402387","id":"PMC_33402387","title":"Targeting the IRAK1-S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma.","date":"2021","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33402387","citation_count":31,"is_preprint":false},{"pmid":"18992325","id":"PMC_18992325","title":"Down-regulation of IRAK-4 is a component of LPS- and CpG DNA-induced tolerance in macrophages.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18992325","citation_count":31,"is_preprint":false},{"pmid":"11934858","id":"PMC_11934858","title":"Pelle kinase is activated by autophosphorylation during Toll signaling in Drosophila.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11934858","citation_count":30,"is_preprint":false},{"pmid":"17917042","id":"PMC_17917042","title":"Inherited human IRAK-4 deficiency: an update.","date":"2007","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/17917042","citation_count":30,"is_preprint":false},{"pmid":"23233309","id":"PMC_23233309","title":"Association of an activity-enhancing variant of IRAK1 and an MECP2-IRAK1 haplotype with increased susceptibility to rheumatoid arthritis.","date":"2013","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/23233309","citation_count":30,"is_preprint":false},{"pmid":"34906138","id":"PMC_34906138","title":"IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies.","date":"2021","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34906138","citation_count":29,"is_preprint":false},{"pmid":"11745395","id":"PMC_11745395","title":"IRAK and TAK1 are required for IL-18-mediated signaling.","date":"2001","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11745395","citation_count":26,"is_preprint":false},{"pmid":"36765034","id":"PMC_36765034","title":"IRAK-M suppresses the activation of microglial NLRP3 inflammasome and GSDMD-mediated pyroptosis through inhibiting IRAK1 phosphorylation during experimental autoimmune encephalomyelitis.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36765034","citation_count":25,"is_preprint":false},{"pmid":"25550857","id":"PMC_25550857","title":"Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25550857","citation_count":25,"is_preprint":false},{"pmid":"29797599","id":"PMC_29797599","title":"Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29797599","citation_count":25,"is_preprint":false},{"pmid":"24792928","id":"PMC_24792928","title":"PKCδ-IRAK1 axis regulates oxidized LDL-induced IL-1β production in monocytes.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/24792928","citation_count":25,"is_preprint":false},{"pmid":"35022428","id":"PMC_35022428","title":"Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35022428","citation_count":24,"is_preprint":false},{"pmid":"31914413","id":"PMC_31914413","title":"A highly selective inhibitor of interleukin-1 receptor-associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinase.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31914413","citation_count":24,"is_preprint":false},{"pmid":"29611775","id":"PMC_29611775","title":"Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.","date":"2018","source":"Immunological investigations","url":"https://pubmed.ncbi.nlm.nih.gov/29611775","citation_count":24,"is_preprint":false},{"pmid":"16212909","id":"PMC_16212909","title":"Novel role and regulation of the interleukin-1 receptor associated kinase (IRAK) family proteins.","date":"2005","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16212909","citation_count":24,"is_preprint":false},{"pmid":"17603113","id":"PMC_17603113","title":"A gain-of-function screen for genes that influence axon guidance identifies the NF-kappaB protein dorsal and reveals a requirement for the kinase Pelle in Drosophila photoreceptor axon targeting.","date":"2007","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17603113","citation_count":23,"is_preprint":false},{"pmid":"27188726","id":"PMC_27188726","title":"G2013 modulates TLR4 signaling pathway in IRAK-1 and TARF-6 dependent and miR-146a independent manner.","date":"2016","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/27188726","citation_count":23,"is_preprint":false},{"pmid":"37954584","id":"PMC_37954584","title":"IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37954584","citation_count":22,"is_preprint":false},{"pmid":"34279092","id":"PMC_34279092","title":"Discovery of Highly Potent and Selective IRAK1 Degraders to Probe Scaffolding Functions of IRAK1 in ABC DLBCL.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34279092","citation_count":22,"is_preprint":false},{"pmid":"29038250","id":"PMC_29038250","title":"Inhibition of IRAK1 Ubiquitination Determines Glucocorticoid Sensitivity for TLR9-Induced Inflammation in Macrophages.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29038250","citation_count":22,"is_preprint":false},{"pmid":"27270491","id":"PMC_27270491","title":"IRAK regulates macrophage foam cell formation by modulating genes involved in cholesterol uptake and efflux.","date":"2016","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/27270491","citation_count":21,"is_preprint":false},{"pmid":"28665693","id":"PMC_28665693","title":"Critical Role of IRAK-M in Regulating Antigen-Induced Airway Inflammation.","date":"2017","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28665693","citation_count":21,"is_preprint":false},{"pmid":"35195809","id":"PMC_35195809","title":"miR-146a contributes to atherosclerotic plaque stability by regulating the expression of TRAF6 and IRAK-1.","date":"2022","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/35195809","citation_count":20,"is_preprint":false},{"pmid":"10512628","id":"PMC_10512628","title":"Formation and biochemical characterization of tube/pelle death domain complexes: critical regulators of postreceptor signaling by the Drosophila toll receptor.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10512628","citation_count":20,"is_preprint":false},{"pmid":"23776703","id":"PMC_23776703","title":"IRAK-M expression limits dendritic cell activation and proinflammatory cytokine production in response to Helicobacter pylori.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23776703","citation_count":20,"is_preprint":false},{"pmid":"14684752","id":"PMC_14684752","title":"Regulation of interleukin receptor-associated kinase (IRAK) phosphorylation and signaling by iota protein kinase C.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14684752","citation_count":20,"is_preprint":false},{"pmid":"26474173","id":"PMC_26474173","title":"Pelle Modulates dFoxO-Mediated Cell Death in Drosophila.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26474173","citation_count":19,"is_preprint":false},{"pmid":"34954030","id":"PMC_34954030","title":"Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis in ApoE-/- mice.","date":"2021","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/34954030","citation_count":19,"is_preprint":false},{"pmid":"24398261","id":"PMC_24398261","title":"Molecular cloning and expression of IRAK-4, IL-17 and I-κB genes in Haliotis rufescens challenged with Vibrio anguillarum.","date":"2014","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24398261","citation_count":19,"is_preprint":false},{"pmid":"31846774","id":"PMC_31846774","title":"Molecular characterization, expression and functional analysis of IRAK1 and IRAK4 in Nile tilapia (Oreochromis niloticus).","date":"2019","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31846774","citation_count":18,"is_preprint":false},{"pmid":"28207326","id":"PMC_28207326","title":"Micro RNA-146a But Not IRAK1 is Associated with Rheumatoid Arthritis in the Tunisian Population.","date":"2017","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/28207326","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49560,"output_tokens":8303,"usd":0.136612,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17964,"output_tokens":6396,"usd":0.12486,"stage2_stop_reason":"end_turn"},"total_usd":0.261472,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"IRAK1 (IRAK) was identified as a serine/threonine protein kinase that rapidly associates with the IL-1 receptor type I complex upon IL-1 stimulation and becomes phosphorylated, linking IL-1R engagement to NF-κB activation.\",\n      \"method\": \"Protein purification, cDNA cloning, co-immunoprecipitation with IL-1RI complex, phosphorylation assay in HEK293 and HeLa cells\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct biochemical purification and cloning with functional receptor-association assay; foundational paper replicated across subsequent studies\",\n      \"pmids\": [\"8599092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The Drosophila IRAK1 ortholog Pelle encodes a serine/threonine protein kinase whose catalytic domain is required for biological activity (nuclear import of Dorsal to establish dorsoventral polarity); site-directed mutagenesis of the kinase domain abolishes function.\",\n      \"method\": \"Molecular cloning, DNA sequence analysis, microinjection of in vitro-synthesized transcripts with site-directed mutations in Drosophila embryos\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis of active-site with direct functional readout in vivo; foundational paper\",\n      \"pmids\": [\"8440018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Pelle (Drosophila IRAK1 ortholog) functions downstream of Tube in the Toll signaling pathway; Pelle and Tube interact directly, and Tube activates Pelle, as shown by gain-of-function alleles and direct protein interaction.\",\n      \"method\": \"Genetic epistasis with gain-of-function alleles, direct protein-protein interaction assay in Drosophila embryos\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genetic epistasis combined with direct interaction demonstration; replicated in subsequent structural and biochemical studies\",\n      \"pmids\": [\"7527496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Pelle (Drosophila IRAK1 ortholog) is recruited to the plasma membrane via interaction with Tube; membrane targeting of Pelle catalytic domain alone is sufficient to induce ventral fates, and Tube-Pelle interaction is required for signal transduction downstream of Toll.\",\n      \"method\": \"Immunolocalization, yeast two-hybrid, membrane-targeted fusion protein assay in Drosophila embryos\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interaction assays plus functional rescue with membrane-targeting; replicated across multiple labs\",\n      \"pmids\": [\"7635064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"IRAK1 functions as a proximal mediator of IL-1R-induced NF-κB activation, forming a signaling complex with IL-1R, IRAK-2, and MyD88; dominant-negative forms of IRAK-2 or MyD88 attenuate IL-1R-mediated NF-κB activation, establishing IRAK1 at the apex of this complex.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative overexpression, NF-κB reporter assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal complex formation and dominant-negative epistasis; widely replicated\",\n      \"pmids\": [\"9374458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Pelle (Drosophila IRAK1) directly binds the Toll intracytoplasmic domain; Pelle autophosphorylation prevents binding to both Toll and Tube; Pelle phosphorylates Toll within the Pelle-interaction region, providing a regulatory feedback mechanism.\",\n      \"method\": \"In vitro binding assay with recombinant proteins, autophosphorylation kinase assay, deletion mapping\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with recombinant proteins and mutagenesis, single lab\",\n      \"pmids\": [\"9806920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The crystal structure of the Pelle–Tube death domain heterodimer was solved; the two death domains form a six-helix bundle in a linear array, with the Tube death domain having an insertion and C-terminal tail making critical contacts; in vivo mutagenesis confirmed that the major heterodimer interface is essential for activity.\",\n      \"method\": \"X-ray crystallography, in vivo functional mutagenesis in Drosophila\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with orthogonal in vivo mutagenesis validation\",\n      \"pmids\": [\"10589682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pelle and Tube death domains form a heterodimeric complex in vitro with a Kd of ~0.5 µM, as demonstrated by yeast two-hybrid, purified protein interaction, surface plasmon resonance, analytical ultracentrifugation, and isothermal titration calorimetry; mutant Tube proteins unable to support signaling also fail to bind Pelle.\",\n      \"method\": \"Yeast two-hybrid, protein purification, surface plasmon resonance, analytical ultracentrifugation, isothermal titration calorimetry\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biophysical methods measuring direct interaction with quantitative Kd\",\n      \"pmids\": [\"10512628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pelle oligomerization (not membrane association alone) is required for its full activation during Toll signaling; the novel protein Pellino associates with the kinase domain of Pelle.\",\n      \"method\": \"Deletion analysis, oligomerization assays, co-immunoprecipitation in Drosophila cells\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional deletion analysis and pulldown, single lab\",\n      \"pmids\": [\"10330490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Mouse IRAK1 ortholog (mPLK) is a protein kinase that can autophosphorylate and phosphorylate IκBα in vitro, linking it biochemically to NF-κB regulation.\",\n      \"method\": \"Recombinant protein expression in bacteria, in vitro kinase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro kinase assay, single lab, no mutagenesis\",\n      \"pmids\": [\"8663605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Pelle (Drosophila IRAK1) physically and functionally interacts with dTRAF2 (homolog of human TRAF6); Pelle phosphorylates dTRAF2 in vitro, and co-expression of Pelle and dTRAF2 synergistically activates Dorsal/NF-κB in Schneider cells.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, co-transfection NF-κB reporter assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct kinase assay (Pelle phosphorylates dTRAF2) plus functional epistasis; two orthogonal methods\",\n      \"pmids\": [\"11447260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Pelle (Drosophila IRAK1) functions as a feedback regulator that downregulates Tube plasma membrane recruitment; kinase-inactive Pelle or elimination of Tube-Pelle interaction dramatically increases Tube recruitment to the ventral membrane.\",\n      \"method\": \"Confocal immunofluorescence microscopy, allelic series analysis, autophosphorylation and Tube phosphorylation assays\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization imaging plus biochemical kinase assays, multiple alleles tested\",\n      \"pmids\": [\"11731453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Pelle (Drosophila IRAK1) undergoes concentration-dependent autophosphorylation that is enhanced by activated Toll signaling; autophosphorylated Pelle is far more active in vitro than unphosphorylated Pelle, establishing autophosphorylation as the activation mechanism.\",\n      \"method\": \"In vitro kinase assay with recombinant Pelle, transfected Schneider cell phosphorylation assay, gain-of-function Toll mutant analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with quantitative kinase activity measurement; corroborated by in vivo data\",\n      \"pmids\": [\"11934858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"IRAK-4 phosphorylates IRAK1 and is required upstream of IRAK1 for IL-1-induced activation and modification of IRAK1; overexpression of dominant-negative IRAK-4 blocks IL-1-induced activation of IRAK1.\",\n      \"method\": \"In vitro kinase assay (IRAK-4 phosphorylates IRAK1), dominant-negative overexpression, co-immunoprecipitation in a stimulus-dependent manner\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct phosphorylation assay plus epistasis; replicated by independent labs\",\n      \"pmids\": [\"11960013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"IRAK-M prevents dissociation of IRAK1 and IRAK-4 from MyD88 and blocks formation of IRAK1-TRAF6 complexes, thereby negatively regulating TLR/IL-1R signaling; IRAK-M-deficient cells show increased cytokine production and reduced endotoxin tolerance.\",\n      \"method\": \"Genetic knockout (IRAK-M-/- mice), co-immunoprecipitation of IRAK1-MyD88 and IRAK1-TRAF6 complexes, cytokine measurement\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined molecular phenotype (disrupted IRAK1 complex dissociation) confirmed by Co-IP; widely replicated\",\n      \"pmids\": [\"12150927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"IRAK-4 kinase activity is required for optimal recruitment and activation of IRAK1 upon IL-1 stimulation; IRAK-4-deficient cells reconstituted with kinase-inactive IRAK-4 show impaired IRAK1 activation, NF-κB and JNK signaling, though some signals remain kinase-independent.\",\n      \"method\": \"IRAK-4-deficient cell reconstitution with wild-type or kinase-inactive IRAK-4, IRAK1 activation assay, NF-κB and JNK reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic reconstitution with kinase-dead mutant, multiple downstream readouts; replicated in other labs\",\n      \"pmids\": [\"15292196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"IRAK1's death domain (but not its kinase activity) is required for NF-κB activation in response to IL-18; the N-proximal undetermined region of IRAK1 is required for NF-κB but not JNK activation in response to IL-18, indicating IRAK1 is a signaling branchpoint; TAK1/TAB1 acts downstream of IRAK1 in IL-18 signaling.\",\n      \"method\": \"IRAK1-deficient mutant cell line (I1A), domain-deletion mutant analysis, dominant-negative TAK1 overexpression, TAB1 phosphorylation assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined cell line lacking IRAK1 plus domain mutant analysis, two signaling readouts, single lab\",\n      \"pmids\": [\"11745395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IRAK1 translocates to the nucleus upon IL-1 or LPS stimulation, binds the promoter of the NF-κB-regulated gene IκBα, enhances NF-κB p65 binding to the IκBα promoter, and phosphorylates histone H3 at serine 10 in vitro and in vivo, revealing a nuclear function for IRAK1 in NF-κB transcriptional activation.\",\n      \"method\": \"Nuclear fractionation, chromatin immunoprecipitation (ChIP), in vitro histone H3 kinase assay, NF-κB transcriptional reporter assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus in vitro kinase assay plus fractionation, single lab, two orthogonal methods\",\n      \"pmids\": [\"18276832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Both IRAK1 and IRAK4 directly phosphorylate the TLR adaptor Mal (MyD88 adaptor-like), and this phosphorylation promotes ubiquitination and proteasomal degradation of Mal; kinase-inactive forms of either IRAK have no effect on Mal degradation, establishing Mal as a substrate.\",\n      \"method\": \"In vitro kinase assay (IRAK1/IRAK4 phosphorylate Mal), co-expression ubiquitination assay, IRAK1/4 inhibitor treatment, siRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct in vitro kinase assay plus kinase-dead controls plus pharmacological inhibitor; single lab, two orthogonal methods\",\n      \"pmids\": [\"20400509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Endotoxin tolerance ablates K63-linked polyubiquitination of IRAK1 and TRAF6, compromises assembly of IRAK1-TRAF6 and IRAK1-IKKγ signaling platforms, and this coincides with increased A20 expression and sustained A20-IRAK1 associations; A20 shRNA knockdown abolishes LPS tolerance, establishing A20 as the deubiquitinase that targets IRAK1 ubiquitination.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K63-linked), A20 overexpression/shRNA knockdown, NF-κB reporter assay in THP1 cells and human monocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (IP, ubiquitination assay, shRNA rescue); mechanistically defines A20-IRAK1 axis in tolerance\",\n      \"pmids\": [\"21220427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IRAK1 kinase activity is required for TLR-triggered rapid (priming-independent) NLRP3 inflammasome activation; IRAK1-deficient macrophages show compromised rapid caspase-1 cleavage, pyroptosis, and NLRP3 complex assembly upon simultaneous TLR and NLRP3 activation by Listeria monocytogenes.\",\n      \"method\": \"IRAK1-deficient macrophages (genetic KO), caspase-1 cleavage assay, pyroptosis assay, NLRP3 complex immunoprecipitation, pharmacological kinase inhibition\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple downstream readouts (caspase-1, pyroptosis, complex assembly) plus pharmacological validation, single lab\",\n      \"pmids\": [\"24379360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Pelle (Drosophila IRAK1) acts as an IκB kinase (IKK) functional equivalent in the Toll pathway, directly phosphorylating Cactus (IκBα homolog) to trigger its βTrCP/Slimb-dependent ubiquitination and proteasomal degradation, enabling Dorsal nuclear entry.\",\n      \"method\": \"Genetic epistasis, Cactus phosphorylation assay, Slimb (βTrCP) requirement assay in cultured Drosophila cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and cell-based epistasis, single lab; direct phosphorylation inference from pathway analysis\",\n      \"pmids\": [\"24086459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The crystal structure of the human IRAK1 kinase domain in complex with a small-molecule inhibitor was solved; the IRAK1 kinase domain is constitutively monomeric regardless of phosphorylation state (unlike IRAK4 which homodimerizes when unphosphorylated); phosphorylated IRAK4 kinase domain forms heterodimers with IRAK1 kinase domain, revealing a two-step activation mechanism in the Myddosome.\",\n      \"method\": \"X-ray crystallography, size-exclusion chromatography, phosphorylation-state controlled heterodimer assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus orthogonal biochemical dimerization assays; rigorous single study with multiple methods\",\n      \"pmids\": [\"29208712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IRAK1 is inactive in unstimulated cells and is activated by IL-1 or TLR stimulation in human cells; this activation is not prevented by pharmacological IRAK4 inhibition and is not reversed by dephosphorylation/deubiquitylation, suggesting IRAK1 is activated by an allosteric mechanism induced by its interaction with IRAK4 rather than by a covalent modification.\",\n      \"method\": \"Novel cell-extract kinase assays using Pellino1 as substrate, specific pharmacological IRAK1/IRAK4 inhibitors, phosphatase/deubiquitylase treatment in HEK293, THP1 monocytes, primary human macrophages\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — novel quantitative kinase assays with pharmacological controls in multiple human cell types; multiple orthogonal approaches\",\n      \"pmids\": [\"28512203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Atypical protein kinase C iota (PKCι) phosphorylates IRAK1 at Thr66 within the death domain; mutation of Thr66 to Ala impairs IRAK1 autokinase activity and reduces PKCι-IRAK1 association, impairing NGF- and IL-1-induced NF-κB activation; PKCι lies upstream of IRAK1 in the NF-κB pathway.\",\n      \"method\": \"In vitro kinase assay (PKCι phosphorylates IRAK1 peptide), site-directed mutagenesis (T66A), co-immunoprecipitation, NF-κB reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase assay plus mutagenesis plus Co-IP, single lab\",\n      \"pmids\": [\"14684752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"K48-linked ubiquitination of IRAK1 at Lys134 by β-TrCP is required for TLR9-induced IRAK1 membrane-to-cytoplasm trafficking and downstream NF-κB/MAPK activation; glucocorticoid receptor physically interacts with IRAK1 and interferes with β-TrCP-IRAK1 interaction to suppress TLR9-specific (not TLR4) inflammation.\",\n      \"method\": \"Co-immunoprecipitation (GR-IRAK1 interaction), ubiquitination assay (K48-linked at Lys134), IRAK1 K134 mutation, macrophage glucocorticoid receptor knockout, NF-κB/MAPK activation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct interaction demonstrated, site-specific ubiquitination mapped by mutagenesis, genetic KO validation, multiple readouts; single lab\",\n      \"pmids\": [\"29038250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Viperin interacts with both IRAK1 and TRAF6; IRAK1 and TRAF6 together stimulate viperin enzymatic activity ~10-fold; TRAF6-mediated K63-linked ubiquitination of IRAK1 requires the association of viperin with both IRAK1 and TRAF6, coupling innate immune signaling to antiviral ddhCTP synthesis.\",\n      \"method\": \"Co-immunoprecipitation (viperin-IRAK1-TRAF6 in HEK293T), viperin activity reconstitution assay, ubiquitination assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus reconstituted enzymatic assay; single lab, two orthogonal methods\",\n      \"pmids\": [\"30872404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"IRAK1 drives radiotherapy resistance via a pathway involving IRAK4 and TRAF6, but not MyD88; radiation-activated IRAK1 prevents PIDDosome-mediated caspase-2 apoptosis; IRAK1 requires PIN1 (a prolyl isomerase) for its activation in response to ionizing radiation.\",\n      \"method\": \"Genetic IRAK1 inhibition/KO in tumor models, epistasis with MyD88/TRAF6/IRAK4 knockdown, caspase-2 and PIDDosome assays, pharmacological IRAK1-PIN1 co-inhibition in xenograft models\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in multiple models with defined molecular readouts (PIDDosome, caspase-2), pharmacological validation; single lab, orthogonal methods\",\n      \"pmids\": [\"30664786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"IRAK1/4 signaling activates the E3 ubiquitin ligase TRAF6, increasing K63-linked ubiquitination and enhancing stability of the antiapoptotic protein MCL1; IRAK inhibition reduces MCL1 stability, sensitizing T-ALL cells to apoptosis-inducing combination therapy.\",\n      \"method\": \"shRNA knockdown of IRAK1/IRAK4, pharmacological IRAK1/4 inhibition, K63-ubiquitination assay of TRAF6, MCL1 stability assay, leukemia xenograft model\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological KD with ubiquitination and protein stability assays; single lab, multiple readouts\",\n      \"pmids\": [\"25642772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In MDS/AML, IRAK1 and IRAK4 operate via noncanonical MyD88-independent pathways; inhibiting IRAK4 elicits functional compensation by IRAK1; combined IRAK1+IRAK4 cotargeting suppresses leukemic stem/progenitor cell function and induces differentiation; IRAK1/IRAK4 preserve the undifferentiated state through pathways converging on PRC2 and JAK-STAT signaling.\",\n      \"method\": \"Genetic knockdown/knockout, dual IRAK1/4 inhibitor (KME-2780), proteomics, MyD88 genetic epistasis, xenograft and patient-derived cell models\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological approaches with genomic/proteomic analyses in patient-derived models; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"37172199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In FGFR1-driven hematological malignancies (SCLL), IRAK1 promotes immune evasion by regulating IFN-γ production from leukemia cells, which induces MDSC expansion to suppress T cell-mediated tumor killing; IRAK1 KO eliminates disease in immunocompetent but not immunodeficient mice.\",\n      \"method\": \"CRISPR/Cas9 IRAK1 knockout, syngeneic xenograft, T-cell depletion, IFNG KO cells, IFNGR1-null host mice, cytokine profiling\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with rigorous immune depletion and genetic epistasis; single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"34906138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IRAK1 binds to PRDX1 and prevents its ubiquitination and degradation by E3 ubiquitin ligase HECTD3 (whose DOC and HECT domains both interact with PRDX1), thereby promoting radioresistance in glioma by suppressing autophagic cell death.\",\n      \"method\": \"Co-IP, LC-MS/MS, GST pull-down, ubiquitination assay, IRAK1 knockdown with in vitro and in vivo radiosensitivity assays, ChIP and dual-luciferase for FOXA2-IRAK1 transcription axis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple interaction methods (Co-IP, GST pulldown, MS) plus functional rescue; single lab\",\n      \"pmids\": [\"37031183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IRAK1 scaffolding function (rather than kinase activity) is required for survival of ABC DLBCL cells harboring MyD88 mutation; IRAK1-targeted degraders (PROTACs) potently degrade IRAK1 and inhibit downstream NF-κB signaling and cell proliferation.\",\n      \"method\": \"IRAK1 PROTAC degraders, cell viability assays, NF-κB pathway reporter assay in MyD88-mutant ABC DLBCL cells\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological protein degradation with downstream pathway readout; scaffolding vs. kinase distinction established by comparing degrader vs. kinase inhibitor effects\",\n      \"pmids\": [\"34279092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Pelle (Drosophila IRAK1) physically interacts with dFoxO and directly phosphorylates dFoxO, promoting its cytoplasmic-to-nuclear translocation and upregulation of Thor/4E-BP transcription, revealing a Toll-independent role for Pelle in regulating apoptotic cell death.\",\n      \"method\": \"Co-immunoprecipitation (Pelle-dFoxO), in vitro kinase assay (Pelle phosphorylates dFoxO), nuclear translocation assay, genetic loss-of-function in Drosophila wing tissue\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct kinase assay plus Co-IP plus in vivo genetic phenotype; single lab\",\n      \"pmids\": [\"26474173\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"IRAK1 is a serine/threonine kinase that, upon IL-1R or TLR stimulation, is recruited to the receptor complex via death-domain interactions with MyD88/IRAK4, where it is activated allosterically through heterodimerization with phosphorylated IRAK4; once active, IRAK1 undergoes K63-linked polyubiquitination by TRAF6, dissociates from the receptor complex to activate downstream NF-κB, MAPK, and inflammasome (NLRP3) pathways, and also translocates to the nucleus to directly phosphorylate histone H3 and enhance NF-κB transcriptional output; its activity is negatively regulated by IRAK-M (which blocks IRAK1-TRAF6 complex formation), A20 (which deubiquitinates IRAK1), and autophosphorylation-dependent dissociation from the receptor, while additional non-canonical functions include regulation of apoptosis via dFoxO phosphorylation, MCL1 stabilization via TRAF6/K63-ubiquitination, and radioresistance via PRDX1 stabilization and PIN1-dependent activation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"IRAK1 is a serine/threonine protein kinase that serves as a proximal signal transducer of the IL-1 receptor and Toll-like receptor family, coupling receptor engagement to NF-κB activation [#0, #4]. Its core signaling logic is conserved from the Drosophila ortholog Pelle, which acts downstream of Tube in the Toll dorsoventral patterning pathway: Pelle is recruited to the membrane through a death-domain heterodimer with Tube and, once oligomerized, drives nuclear import of the NF-κB-like factor Dorsal [#2, #3, #6, #8]. In the mammalian pathway IRAK1 assembles with MyD88 and IRAK-2 at the receptor [#4] and is recruited and activated by upstream IRAK4, whose kinase activity phosphorylates IRAK1 and is required for optimal IRAK1 activation [#13, #15]; structurally, the IRAK1 kinase domain remains monomeric and is licensed by forming a heterodimer with phosphorylated IRAK4, defining a two-step Myddosome activation mechanism that operates allosterically rather than through a single covalent mark [#22, #23]. Activated IRAK1 feeds into NF-κB, MAPK/JNK, and the TAK1/TAB1 module, and acts as a signaling branchpoint in which the death domain and N-proximal region, not kinase activity, are needed for some outputs [#16]; IRAK1 also enables priming-independent NLRP3 inflammasome assembly and rapid caspase-1 activation in a kinase-dependent manner [#20]. Beyond cytoplasmic signaling, IRAK1 translocates to the nucleus, binds NF-κB target promoters, and phosphorylates histone H3 at serine 10 to enhance transcriptional output [#17]. IRAK1 directly phosphorylates substrates including the adaptor Mal, targeting it for ubiquitin-dependent degradation [#18]. Its activity is tuned by multiple negative regulators—IRAK-M blocks IRAK1 dissociation from MyD88 and formation of IRAK1-TRAF6 complexes [#14], the deubiquitinase A20 reverses K63-linked IRAK1 ubiquitination during endotoxin tolerance [#19], and the glucocorticoid receptor interferes with β-TrCP-mediated K48 ubiquitination required for IRAK1 trafficking [#25]. IRAK1 additionally functions in malignancy and stress responses, promoting radioresistance through PIN1-dependent activation and PRDX1 stabilization, stabilizing the anti-apoptotic protein MCL1 via TRAF6/K63-ubiquitination, and sustaining leukemic stem/progenitor states, in part through scaffolding rather than catalytic functions [#27, #28, #31, #32, #29].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established that the IRAK1 ortholog is a catalytically essential kinase whose function is to relay a receptor signal to nuclear transcription factor activation, defining the gene as an essential transducer rather than a structural component.\",\n      \"evidence\": \"Cloning and active-site mutagenesis of Drosophila Pelle with in vivo Dorsal nuclear-import readout\",\n      \"pmids\": [\"8440018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian substrates not yet identified\", \"Mechanism of kinase activation undefined\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Showed that the kinase is positioned at the membrane through an upstream death-domain adaptor, answering how the cytoplasmic kinase is recruited to an activated receptor.\",\n      \"evidence\": \"Yeast two-hybrid, immunolocalization, and membrane-targeted fusion rescue of Pelle-Tube interaction in Drosophila embryos\",\n      \"pmids\": [\"7635064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and dynamics of recruitment not resolved\", \"Connection to receptor occupancy quantitative only later\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identified mammalian IRAK1 biochemically and placed it physically at the IL-1 receptor, connecting IL-1R engagement to NF-κB activation in human cells.\",\n      \"evidence\": \"Protein purification, cDNA cloning, and Co-IP with IL-1RI plus phosphorylation assay in HEK293/HeLa; parallel mouse mPLK in vitro kinase assay on IκBα\",\n      \"pmids\": [\"8599092\", \"8663605\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physiological substrates unproven (IκBα phosphorylation only in vitro)\", \"Upstream activating kinase unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Defined the proximal receptor complex composition, establishing IRAK1 at the apex of an IL-1R/MyD88/IRAK-2 signaling assembly.\",\n      \"evidence\": \"Co-IP and dominant-negative epistasis with NF-κB reporter assays\",\n      \"pmids\": [\"9374458\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of assembly and activation step undefined\", \"How IRAK1 leaves the complex unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Revealed an autoregulatory feedback loop in which kinase autophosphorylation governs receptor and adaptor binding, explaining signal termination.\",\n      \"evidence\": \"In vitro binding and autophosphorylation kinase assays with recombinant Pelle and Toll/Tube\",\n      \"pmids\": [\"9806920\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conservation of Toll-direct phosphorylation in mammals not shown\", \"Single-lab in vitro reconstitution\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Determined the structural basis of kinase recruitment by solving the death-domain heterodimer and measuring its affinity, validating the interface as functionally essential.\",\n      \"evidence\": \"X-ray crystallography of Pelle-Tube death-domain bundle, SPR/AUC/ITC affinity measurement, and in vivo mutagenesis\",\n      \"pmids\": [\"10589682\", \"10512628\", \"10330490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian Myddosome geometry not yet addressed\", \"Role of oligomerization beyond membrane association partially defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Established the upstream kinase relationship and the activation mechanism, showing IRAK4 phosphorylates and is required to activate IRAK1, and that autophosphorylation potentiates kinase activity.\",\n      \"evidence\": \"In vitro IRAK4-on-IRAK1 phosphorylation assay with dominant-negative epistasis; concentration-dependent Pelle autophosphorylation kinase assays\",\n      \"pmids\": [\"11960013\", \"11934858\", \"11731453\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether activation is covalent or allosteric not yet distinguished\", \"Distinct kinase-dependent vs kinase-independent outputs unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined the principal physiological brake on IRAK1 signaling, showing IRAK-M prevents IRAK1 dissociation from MyD88 and blocks IRAK1-TRAF6 complex formation.\",\n      \"evidence\": \"IRAK-M knockout mice with Co-IP of IRAK1 complexes and cytokine/tolerance phenotyping\",\n      \"pmids\": [\"12150927\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of complex stabilization not structurally defined\", \"Other negative regulators not yet known\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Uncovered a nuclear role for IRAK1, showing it directly modifies chromatin at NF-κB target genes to enhance transcription.\",\n      \"evidence\": \"Nuclear fractionation, ChIP at the IκBα promoter, and in vitro/in vivo histone H3 S10 kinase assay\",\n      \"pmids\": [\"18276832\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear translocation mechanism unknown\", \"Genome-wide chromatin targets not mapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified a direct IRAK1 substrate, showing IRAK1 phosphorylates the TLR adaptor Mal to drive its degradation, providing a kinase-dependent feedback on signaling.\",\n      \"evidence\": \"In vitro kinase assay with kinase-dead controls, ubiquitination assay, inhibitor and siRNA validation\",\n      \"pmids\": [\"20400509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of Mal turnover not quantified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined the deubiquitinase that resets IRAK1, showing A20 removes K63-linked ubiquitin from IRAK1 during endotoxin tolerance and disrupts downstream platform assembly.\",\n      \"evidence\": \"Co-IP, K63 ubiquitination assays, and A20 shRNA rescue in THP1 cells and human monocytes\",\n      \"pmids\": [\"21220427\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct A20 catalysis on IRAK1 inferred from association\", \"Site of K63 linkage on IRAK1 not mapped here\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Expanded IRAK1 output to inflammasome control, showing kinase activity is required for rapid priming-independent NLRP3 activation.\",\n      \"evidence\": \"IRAK1-deficient macrophages with caspase-1 cleavage, pyroptosis, NLRP3 complex IP, and inhibitor validation\",\n      \"pmids\": [\"24379360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct IRAK1 substrate within the NLRP3 module unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved the long-standing question of how IRAK1 is activated, showing the IRAK1 kinase domain is monomeric and is licensed allosterically by heterodimerization with phosphorylated IRAK4 rather than by a single covalent mark.\",\n      \"evidence\": \"Crystal structure of human IRAK1 kinase domain, SEC dimerization assays, and phosphatase/deubiquitylase-resistant activation in multiple human cell types using Pellino1 substrate assays\",\n      \"pmids\": [\"29208712\", \"28512203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise allosteric conformational change not visualized\", \"Relationship between allosteric activation and downstream ubiquitination not fully integrated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified an additional upstream regulatory input, with atypical PKCι phosphorylating IRAK1 at Thr66 to support autokinase activity and NF-κB signaling.\",\n      \"evidence\": \"In vitro kinase assay, T66A mutagenesis, Co-IP, and NF-κB reporter\",\n      \"pmids\": [\"14684752\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological contexts requiring PKCι input not delineated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined a ubiquitin-dependent trafficking step and its regulation, showing β-TrCP-mediated K48 ubiquitination at Lys134 drives TLR9-induced IRAK1 membrane-to-cytoplasm trafficking and that the glucocorticoid receptor suppresses this.\",\n      \"evidence\": \"Co-IP, site-specific ubiquitination mapping with K134 mutation, macrophage GR knockout, and NF-κB/MAPK readouts\",\n      \"pmids\": [\"29038250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TLR-specificity mechanism (TLR9 vs TLR4) not fully explained\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked IRAK1 signaling to antiviral metabolism, showing viperin bridges IRAK1 and TRAF6 to enable IRAK1 K63-ubiquitination and stimulate viperin enzymatic activity.\",\n      \"evidence\": \"Reciprocal Co-IP and viperin activity reconstitution with ubiquitination assays in HEK293T\",\n      \"pmids\": [\"30872404\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance to antiviral defense not established\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established a non-canonical, MyD88-independent IRAK1 function in radioresistance requiring PIN1 and blocking PIDDosome-mediated apoptosis.\",\n      \"evidence\": \"Genetic IRAK1 inhibition/KO in tumor models, epistasis with MyD88/TRAF6/IRAK4, caspase-2/PIDDosome assays, and pharmacological IRAK1-PIN1 co-inhibition in xenografts\",\n      \"pmids\": [\"30664786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of PIN1-dependent IRAK1 activation undefined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Connected IRAK1 to apoptosis control through both a kinase-substrate route in flies and an anti-apoptotic stabilization route in cancer cells.\",\n      \"evidence\": \"Pelle-dFoxO Co-IP, in vitro kinase assay and Drosophila genetics; IRAK1/4 knockdown with TRAF6 K63-ubiquitination and MCL1 stability assays in T-ALL\",\n      \"pmids\": [\"26474173\", \"25642772\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Conservation of dFoxO phosphorylation in mammals not shown\", \"Whether MCL1 stabilization requires IRAK1 kinase activity not resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined oncogenic IRAK1 roles spanning immune evasion, radioresistance via PRDX1 stabilization, and scaffolding-dependent survival, separating catalytic from non-catalytic functions.\",\n      \"evidence\": \"CRISPR IRAK1 KO with immune-depletion epistasis; Co-IP/GST pulldown/MS for PRDX1-HECTD3 axis; IRAK1 PROTAC degraders vs kinase inhibitors in MyD88-mutant DLBCL\",\n      \"pmids\": [\"34906138\", \"37031183\", \"34279092\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality of scaffolding-vs-kinase dependence across tumor types unclear\", \"Each finding from a single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established functional redundancy with IRAK4 in leukemia, showing IRAK4 inhibition triggers IRAK1 compensation and that dual targeting collapses leukemic stem-cell programs.\",\n      \"evidence\": \"Genetic knockdown/KO, dual IRAK1/4 inhibitor, proteomics, MyD88 epistasis, and patient-derived xenograft models\",\n      \"pmids\": [\"37172199\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular link from IRAK1 to PRC2/JAK-STAT not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How IRAK1's allosteric kinase activation, K63/K48 ubiquitination states, nuclear chromatin function, and scaffolding-only roles are integrated into a single regulated cycle, and which functions depend on catalysis versus scaffolding in each disease context, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model of the activated Myddosome with IRAK1 in human cells\", \"Comprehensive in vivo substrate map lacking\", \"Kinase-dependent vs scaffolding contributions not systematically separated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 13, 18, 17, 24]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 9, 18, 33]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [22, 12]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [4, 0]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [32, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 25]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [25, 19]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 4, 14, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4, 13, 22]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [17]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [27, 28, 33]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [28, 29, 30, 31, 32]}\n    ],\n    \"complexes\": [\"Myddosome (MyD88-IRAK4-IRAK1)\", \"IRAK1-TRAF6 complex\", \"NLRP3 inflammasome\"],\n    \"partners\": [\"IRAK4\", \"MyD88\", \"TRAF6\", \"IRAK2\", \"Tube\", \"PRDX1\", \"PIN1\", \"PRKCI\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}